M. Keiserman
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 11
- Rheumatoid Arthritis Research and Therapies 9
- Systemic Lupus Erythematosus Research 2
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- R. Aranda (2 shared papers)Maxime Dougados (2 shared papers)S Songcharoen (2 shared papers)S. Nayiager (2 shared papers)Michael Schiff (2 shared papers)C. Codding (2 shared papers)J-C Becker (1 shared paper)Chia‐Yen Lin (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (8 papers)Lara D. Veeken (1 paper)Arthritis Care & Research (1 paper)Revista Brasileira de Reumatologia (3 papers)PubMed (1 paper)
- Partner nations
- BrazilUnited StatesGermany
In The Last Decade
M. Keiserman
13 papers receiving 662 citations
M. Keiserman's Hit Papers
Peers
Comparison fields: 5 of 51
- Rheumatology 526
- Hematology 144
- Genetics 88
- Immunology 164
- Radiology, Nuclear Medicine and Imaging 114
Countries citing papers authored by M. Keiserman
This map shows the geographic impact of M. Keiserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Keiserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Keiserman more than expected).
Fields of papers citing papers by M. Keiserman
This network shows the impact of papers produced by M. Keiserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Keiserman. The network helps show where M. Keiserman may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Keiserman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate Hit paper breakdown → | 2007 | 430 |
| 2 | 2011 | 158 | |
| 3 | 2011 | 46 | |
| 4 | 2015 | 33 | |
| 5 | 2008 | 13 | |
| 6 | 2020 | 12 | |
| 7 | 2004 | 4 | |
| 8 | Fibrose pulmonar na eslerose sistemica progressiva: frequencia e associacoes clinicas | 1999 | 3 |
| 9 | 2021 | 3 | |
| 10 | Rheumatoid arthritis, transverse myelitis and antiphospholipid antibodies. | 1993 | 2 |
| 11 | 2012 | 2 | |
| 12 | 2020 | 1 | |
| 13 | 2016 | 1 | |
| 14 | 2014 | 1 | |
| 15 | 2017 | 0 |
About M. Keiserman
M. Keiserman is a scholar working on Rheumatology, Genetics, Pathology and Forensic Medicine, Hematology and Immunology, having authored 15 papers that have together received 709 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (9 papers), Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Systemic Lupus Erythematosus Research (2 papers), Bone and Joint Diseases (1 paper), Systemic Sclerosis and Related Diseases (1 paper) and Neurological Complications and Syndromes (1 paper). The work is most often cited by research in Rheumatology (526 citations), Hematology (144 citations), Genetics (88 citations), Immunology (164 citations) and Radiology, Nuclear Medicine and Imaging (114 citations). M. Keiserman has collaborated with scholars based in Brazil, United States and Germany. Frequent co-authors include R. Aranda, Maxime Dougados, S Songcharoen, S. Nayiager, Michael Schiff, C. Codding, J-C Becker, Chia‐Yen Lin, Philippe Cornet and Alberto Berman. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Care & Research, Revista Brasileira de Reumatologia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.